Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U3GA
|
||||
| Former ID |
DCL001244
|
||||
| Drug Name |
SPC5001
|
||||
| Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Phase 1 | [551623] | ||
| Company |
Santaris Pharma A/S
|
||||
| Target and Pathway | |||||
| Target(s) | Proprotein convertase subtilisin/kexin type 9 | Target Info | Inhibitor | [551623] | |
| WikiPathways | PCSK9-mediated LDLR degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.